Jorge Perez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jorge Perez has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Daniela Tardito
Department of Theoretical and Applied Sciences (DiSTA), eCampus University, 22060 Novedrate, Como, Italy
8 shared publications Giorgio Racagni
Center of Neuropharmacology, Institute of Pharmacological Sciences, University of Milan, Milan, Italy
3 shared publications- Raffaella Zanardi
Department of Clinical Neurosciences, Vita-Salute San Raffaele University, 20127 Milan, Italy
3 shared publications E Smeraldi
2 shared publicationsG Racagni
2 shared publications- Giuseppe Maina
Psychiatry Department, San Luigi Gonzaga Hospital, University of Turin, Regione Gonzole, 10, 10043 Orbassano, Italy
2 shared publications
Latest Publications
- 22 March 2002
- Vol. 12 (43) , 21-6
[Implications of cAMP signaling in affective disorders].
The last decade brought about a shift in the theoretical framework, addressing the issue of affective disorders. During this period, the research endeavors have been directed towards investigating the biochemical mechanisms involved in the transduction of informations from the self surface to the cell interior. Nowadays, the emerging picture is that various signal transduction pathways could be linked to the pharmacotherapy and pathophysiology of affective disorders. Among these pathways, in this review the role of the cAMP signaling system will be highlighted. In particular, a summary of the preclinical and clinical data suggesting the involvement of the downstream components of this system in affective disorders will be given. This framework has the potential to improve our knowledge providing clues for the development of novel research strategies in the field of affective disorders.
- 22 March 2002
- Vol. 12 (43) , 21-6
[Implications of cAMP signaling in affective disorders].
The last decade brought about a shift in the theoretical framework, addressing the issue of affective disorders. During this period, the research endeavors have been directed towards investigating the biochemical mechanisms involved in the transduction of informations from the self surface to the cell interior. Nowadays, the emerging picture is that various signal transduction pathways could be linked to the pharmacotherapy and pathophysiology of affective disorders. Among these pathways, in this review the role of the cAMP signaling system will be highlighted. In particular, a summary of the preclinical and clinical data suggesting the involvement of the downstream components of this system in affective disorders will be given. This framework has the potential to improve our knowledge providing clues for the development of novel research strategies in the field of affective disorders.
- 1 February 2002
- Published by Springer Nature in Molecular Psychiatry
- Vol. 7 (2) , 208-212
cAMP signaling pathway in depressed patients with psychotic features
Molecular Psychiatry publishes work aimed at elucidating biological mechanisms underlying psychiatric disorders and their treatment
- 1 February 2002
- Published by Springer Nature in Molecular Psychiatry
- Vol. 7 (2) , 208-212
cAMP signaling pathway in depressed patients with psychotic features
Molecular Psychiatry publishes work aimed at elucidating biological mechanisms underlying psychiatric disorders and their treatment
- 1 January 2002
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 24 (7-8) , 639-646
THE INTERFACE BETWEEN DEPRESSION AND CEREBROVASCULAR DISEASE—SOME HOPE BUT NO HYPE
Medical complications after stroke are an important problem not only for patients, but also for their families and the clinicians who take care of them, thus representing a major public health problem. Among medical illnessess complicating stroke, in the last several years much efforts has been directed to determine the role of affective disorders. Although depression coexisting with stroke has been shown to increase levels of functional disability and reduce the effectiveness of rehabilitation, we still have much to learn about the clinical interface between such disorders. This review focuses on the data concerning the potential relationship between depression and cerebrovascular disease (CVD) and the emerging insights which may be relevant to provide directions for the development of novel research strategies on the pathogenesis and treatment of post-stroke depression.
- 1 January 2002
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 24 (7-8) , 639-646
THE INTERFACE BETWEEN DEPRESSION AND CEREBROVASCULAR DISEASE—SOME HOPE BUT NO HYPE
Medical complications after stroke are an important problem not only for patients, but also for their families and the clinicians who take care of them, thus representing a major public health problem. Among medical illnessess complicating stroke, in the last several years much efforts has been directed to determine the role of affective disorders. Although depression coexisting with stroke has been shown to increase levels of functional disability and reduce the effectiveness of rehabilitation, we still have much to learn about the clinical interface between such disorders. This review focuses on the data concerning the potential relationship between depression and cerebrovascular disease (CVD) and the emerging insights which may be relevant to provide directions for the development of novel research strategies on the pathogenesis and treatment of post-stroke depression.
- 30 June 2001
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 11 (3) , 221-225
The cAMP-dependent protein kinase substrate Rap1 in platelets from patients with obsessive compulsive disorder or schizophrenia
- 30 June 2001
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 11 (3) , 221-225
The cAMP-dependent protein kinase substrate Rap1 in platelets from patients with obsessive compulsive disorder or schizophrenia
- 1 April 2001
- Published by Cambridge University Press (CUP) in CNS Spectrums
- Vol. 6 (4) , 294-305
Implications of the cAMP Signaling Pathway in Psychiatric Disorders: A Systematic Review of the Evidence
The last decade has seen a shift in the theoretical framework addressing the pathophysiology of psychiatric disorders. During this period, research endeavors have been directed toward investigating the biochemical mechanisms involved in the transduction of information from the cell surface to the cell interior. The emerging picture, supported by growing evidence, is that in addition to neurotransmitters and their receptors, various signal transduction pathways may be linked to the pathophysiology of major psychiatric disorders. In this review, the role of one such pathway—the cyclic adenosine monophosphate (cAMP) signaling pathway—will be highlighted. We review data suggesting the involvement of the upstream and downstream components of this system in the pathophysiology of psychiatric disorders.
- 1 April 2001
- Published by Cambridge University Press (CUP) in CNS Spectrums
- Vol. 6 (4) , 294-305
Implications of the cAMP Signaling Pathway in Psychiatric Disorders: A Systematic Review of the Evidence
The last decade has seen a shift in the theoretical framework addressing the pathophysiology of psychiatric disorders. During this period, research endeavors have been directed toward investigating the biochemical mechanisms involved in the transduction of information from the cell surface to the cell interior. The emerging picture, supported by growing evidence, is that in addition to neurotransmitters and their receptors, various signal transduction pathways may be linked to the pathophysiology of major psychiatric disorders. In this review, the role of one such pathway—the cyclic adenosine monophosphate (cAMP) signaling pathway—will be highlighted. We review data suggesting the involvement of the upstream and downstream components of this system in the pathophysiology of psychiatric disorders.
- 14 December 2000
- Published by Springer Nature in Molecular Psychiatry
- Vol. 6 (1) , 44-49
Protein kinase A and Rap1 levels in platelets of untreated patients with major depression
We have recently reported altered levels of protein kinase A and Rap1 in patients with bipolar disorder. The purpose of the current investigation was to assess the levels of these proteins in platelets from untreated euthymic and depressed patients with major unipolar depression. Platelets were collected from 45 drug-free unipolar patients (13 euthymic and 32 depressed) and 45 healthy subjects. The levels of protein kinase A and Rap1 were assessed by Western blot analysis, immunostaining and computer-assisted imaging. The immunolabeling of the regulatory subunit type II of protein kinase A and that of Rap1 was significantly lower in untreated depressed patients compared with untreated euthymic patients and healthy subjects. No significant differences were found in the immunolabeling of both the regulatory type I and the catalytic subunits of protein kinase A among groups. Levels of the regulatory subunit type II of protein kinase A and Rap1 are altered in platelets of unipolar depressive patients. These findings may provide new insight about the relationship between components of cAMP signaling and affective disorders.
- 14 December 2000
- Published by Springer Nature in Molecular Psychiatry
- Vol. 6 (1) , 44-49
Protein kinase A and Rap1 levels in platelets of untreated patients with major depression
We have recently reported altered levels of protein kinase A and Rap1 in patients with bipolar disorder. The purpose of the current investigation was to assess the levels of these proteins in platelets from untreated euthymic and depressed patients with major unipolar depression. Platelets were collected from 45 drug-free unipolar patients (13 euthymic and 32 depressed) and 45 healthy subjects. The levels of protein kinase A and Rap1 were assessed by Western blot analysis, immunostaining and computer-assisted imaging. The immunolabeling of the regulatory subunit type II of protein kinase A and that of Rap1 was significantly lower in untreated depressed patients compared with untreated euthymic patients and healthy subjects. No significant differences were found in the immunolabeling of both the regulatory type I and the catalytic subunits of protein kinase A among groups. Levels of the regulatory subunit type II of protein kinase A and Rap1 are altered in platelets of unipolar depressive patients. These findings may provide new insight about the relationship between components of cAMP signaling and affective disorders.
- 1 March 2000
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 34 (2) , 99-104
Altered Rap1 endogenous phosphorylation and levels in platelets from patients with bipolar disorder
- 1 March 2000
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 34 (2) , 99-104
Altered Rap1 endogenous phosphorylation and levels in platelets from patients with bipolar disorder
- 1 February 2000
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 157 (2) , 284-286
Altered cAMP-Dependent Protein Kinase A in Platelets of Patients With Obsessive-Compulsive Disorder
OBJECTIVE: The purpose of this study was to assess cAMP-dependent protein kinase A in patients with obsessive-compulsive disorder (OCD). METHOD: The levels and the activity of protein kinase A were evaluated in whole platelets obtained from 12 unmedicated patients with OCD and 15 healthy comparison subjects. RESULTS: The immunolabeling of protein kinase A regulatory subunits type I and II were significantly greater but that of the catalytic subunit significantly lower in patients with OCD than in healthy subjects. The cAMP-stimulated activity in patients with OCD was significantly lower than that in healthy subjects. CONCLUSIONS: These data suggest a possible role of protein kinase A in the pathophysiology of OCD.
- 1 February 2000
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 157 (2) , 284-286
Altered cAMP-Dependent Protein Kinase A in Platelets of Patients With Obsessive-Compulsive Disorder
OBJECTIVE: The purpose of this study was to assess cAMP-dependent protein kinase A in patients with obsessive-compulsive disorder (OCD). METHOD: The levels and the activity of protein kinase A were evaluated in whole platelets obtained from 12 unmedicated patients with OCD and 15 healthy comparison subjects. RESULTS: The immunolabeling of protein kinase A regulatory subunits type I and II were significantly greater but that of the catalytic subunit significantly lower in patients with OCD than in healthy subjects. The cAMP-stimulated activity in patients with OCD was significantly lower than that in healthy subjects. CONCLUSIONS: These data suggest a possible role of protein kinase A in the pathophysiology of OCD.